Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-17

Clinical Trial Update: Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating vitamin C, vitamin E, and their combination for restless legs syndrome in patients on hemodialysis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C (ascorbic acid)
  • Vitamin C + Vitamin E (Ascorbic acid; Tocopherol)
  • Vitamin E (tocopherol)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Restless Legs Syndrome, Kidney Failure, Chronic | Phase 2, Phase 3 | Status: COMPLETED